About this trial
This retrospective multicentre cohort evaluates the agreement of measurable residual disease (MRD) detection in acute myeloid leukaemia (AML) using two flow-cytometry gating approaches. Manual expert gating is compared with an unsupervised FlowSOM clustering algorithm across post-induction and post-consolidation samples from 50 adults and 10 paediatric patients treated at Bordeaux University Hospital. The primary hypothesis states that unsupervised gating detects MRD ≥ 0.1 % with sensitivity and specificity comparable to manual gating.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Confirmed diagnosis of acute myeloid leukaemia per ELN 2022
Age ≥ 18 years (adult cohort) or 0-20 years (paediatric cohort)
Inclusion in DATAML Bordeaux database or paediatric haemato-oncology records
Available flow-cytometry MRD data post-induction and post-consolidation 1
Disqualifiers
AML subtypes M3, M6 or M7
Acute leukaemia of ambiguous lineage
Missing or unusable flow-cytometry files for required time points
Trial population
Consecutive adult and paediatric patients diagnosed with ELN-defined AML at Bordeaux University Hospital between 2010 and 2024, for whom routine multiparameter flow-cytometry MRD assessments post-induction and post-consolidation 1 are available
Trial design
Cohort
Retrospective
Treatments tested in this trial
Conventional gating
Diagnostic testManual expert gating of multiparameter flow-cytometry data for MRD
Automated gating
Diagnostic testUnsupervised FlowSOM gating of multiparameter flow-cytometry data for MRD
Treatment groups
Trial outcomes
Primary outcomes
Concordance of MRD ≥ 0.1 % between manual gating and unsupervised FlowSOM gating
Sensitivity, specificity, positive and negative predictive values, Cohen and Fleiss kappa statistics comparing the 3 methods on paired samples
Secondary outcomes
Concordance of flow-cytometry MRD (both methods) with molecular MRD
Sensitivity, specificity, positive and negative predictive values, Cohen and Fleiss kappa statistics comparing the 3 methods on paired samples
Agreement of MRD 0.01-0.1 % between manual and unsupervised gating
Bland-Altman limits of agreement and Pearson or Spearman correlation coefficients calculated from log-transformed MRD percentages to assess agreement between both gating methods in the low MRD range
Concordance of flow-cytometry MRD (both methods) with molecular MRD
Kaplan-Meier survival analyses and multivariable Cox regression models used to compare relapse-free survival (RFS) and overall survival (OS) according to MRD detection method
Inter-operator reproducibility of manual gating
Intra-class correlation coefficients and Fleiss kappa statistics calculated across three independent operators performing manual gating on the same flow-cytometry MRD files
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: